Vinyl Acetate → (1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethyl acetate

HRID 500533Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 500533
[Cl:1][C:2]1[CH:3]=[C:4]([C:8]2[O:12][N:11]=[C:10]([CH:13]([OH:15])[CH3:14])[CH:9]=2)[CH:5]=[CH:6][CH:7]=1.[C:16](OC=C)(=[O:18])[CH3:17]>C1(C)C=CC=CC=1>[C:16]([O:15][C@@H:13]([C:10]1[CH:9]=[C:8]([C:4]2[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[CH:3]=2)[O:12][N:11]=1)[CH3:14])(=[O:18])[CH3:17]

Komponenten

4

Versuchsvorschrift

The title compound of Example 7.1 (106.5 g, 476 mmol) and Novozyme 435® (13 g) are taken up under Ar in dry toluene (1.5 L). After addition of vinyl acetate (66 mL, 716 mmol) the reaction was run at RT over night, followed by filtration over diatomaceous earth and washing with DCM. The solvent was evaporated in vacuo and the crude product was subjected to column chromatography on silica using dichloromethane/methanol (20:1) to give the title compound (50 g, 47%).

Aufarbeitung

  1. waitwas run at RT over night
  2. filtrationfollowed by filtration over diatomaceous earth
  3. washwashing with DCM
  4. customThe solvent was evaporated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-33bacb8dec87444bb34600ae5399f68c
Quelldatensatz
uspto-grants-2010_08
Patentnummer
US07772235B2

Notizen zur Reaktion

Wird geladen…